Charles Schwab Investment Management »

Black Diamond Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 15k 5.07
2023-12-31 $41k 15k 2.81
2023-09-30 $42k 15k 2.87
2023-06-30 $73k 15k 5.05
2022-06-30 $45k 18k 2.50
2022-03-31 $134k 48k 2.78
2021-12-31 $322k 60k 5.34
2021-09-30 $511k 60k 8.47
2021-06-30 $1.4M 119k 12.19
2021-03-31 $2.8M 115k 24.26
2020-12-31 $3.5M 108k 32.05
2020-09-30 $3.2M 107k 30.23
2020-06-30 $3.4M 81k 42.16
2020-03-31 $638k 26k 24.97